Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
The Glimpse Group Inc. Common Stock is a software-infrastructure business based in the US. The Glimpse Group IncCommon Stock shares (VRAR) are listed on the NASDAQ and all prices are listed in US Dollars. The Glimpse Group IncCommon Stock employs 65 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$9.10|
|52-week range||$6.75 - $18.45|
|50-day moving average||$8.48|
|200-day moving average||$8.91|
|Wall St. target price||N/A|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.84|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-2.99%|
|1 month (2021-09-24)||8.33%|
|3 months (2021-07-23)||4.84%|
|6 months (2021-04-21)||N/A|
|1 year (2020-10-21)||N/A|
|2 years (2019-10-21)||N/A|
|3 years (2018-10-21)||N/A|
|5 years (2016-10-21)||N/A|
|Revenue TTM||$3.4 million|
|Gross profit TTM||$2 million|
|Return on assets TTM||-80.5%|
|Return on equity TTM||0%|
|Market capitalisation||$96.5 million|
TTM: trailing 12 months
There are currently 168,111 The Glimpse Group IncCommon Stock shares held short by investors – that's known as The Glimpse Group IncCommon Stock's "short interest". This figure is 49.3% up from 112,604 last month.
There are a few different ways that this level of interest in shorting The Glimpse Group IncCommon Stock shares can be evaluated.
The Glimpse Group IncCommon Stock's "short interest ratio" (SIR) is the quantity of The Glimpse Group IncCommon Stock shares currently shorted divided by the average quantity of The Glimpse Group IncCommon Stock shares traded daily (recently around 236776.05633803). The Glimpse Group IncCommon Stock's SIR currently stands at 0.71. In other words for every 100,000 The Glimpse Group IncCommon Stock shares traded daily on the market, roughly 710 shares are currently held short.
To gain some more context, you can compare The Glimpse Group IncCommon Stock's short interest ratio against those of similar companies.
However The Glimpse Group IncCommon Stock's short interest can also be evaluated against the total number of The Glimpse Group IncCommon Stock shares, or, against the total number of tradable The Glimpse Group IncCommon Stock shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Glimpse Group IncCommon Stock's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 The Glimpse Group IncCommon Stock shares in existence, roughly 20 shares are currently held short) or 0.028% of the tradable shares (for every 100,000 tradable The Glimpse Group IncCommon Stock shares, roughly 28 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against The Glimpse Group IncCommon Stock.
Find out more about how you can short The Glimpse Group IncCommon Stock stock.
We're not expecting The Glimpse Group IncCommon Stock to pay a dividend over the next 12 months.
You may also wish to consider:
The Glimpse Group, Inc. , a virtual reality (VR) and augmented reality (AR) platform company, provides enterprise-focused software, services, and solutions in the United States. It offers QReal, a software that creates and distributes photorealistic 3D and AR content; Adept XR Learning, which provides higher education learning and corporate VR training solutions; PostReality, a cloud-based software as a service solution that enables users to create AR presentations; and XR Platform, a cloud-based, scalable and secure backend infrastructure, including proprietary cloud image recognition technology, online storage, creation and management of subscription plans, and invoicing and payments designed for VR/AR companies. The company also provides D6 VR, a VR-based, analysis, presentation, and education software platform; Immersive Health Group, a digital health platform that leverages VR/AR technology to simplify and streamline complex healthcare challenges in scale; Foretell Reality, an enterprise-grade and easy-to-use solution for meeting others in VR; and Early Adopter, which offers immersive VR and AR EdTech solutions for K-12 schools and pediatric hospital programs. In addition, it offers AUGGD that provides AR software and services primarily for the architecture, engineering, and construction industries; Glimpse Turkey for developing and creating web optimized 3D models, primarily for QReal; and custom specialized AR applications, and white label solutions and services. Further, the company provides Pagoni VR that offers VR video broadcasting solutions, which consists of Chimera that enables real-time communications between a presenter, and local and remote attendees in VR to universities, enterprise, entertainment venues, sports venues, and houses of worship. The company was incorporated in 2016 and is headquartered in New York, New York.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.